Assignee
NEOLEUKIN THERAPEUTICS INC
US·0 granted patents·3 pending applications·0 citations·filing 2020–2021
Top patents by PatentIndex Score
3 records- 0149US2023331858A1Combination therapy using an il-2 receptor agonist and an immune checkpoint inhibitorNEOLEUKIN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0247US2022370563A1Methods of administration of il-2 receptor agonistsNEOLEUKIN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0341US2023340071A1Interleukin-2 Receptor Beta (IL-2RB) Binding PolypeptidesNEOLEUKIN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEOLEUKIN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →